Innovative Debt Solutions
Tailored Growth Capital
Announcements
Neurent Medical Secures €25 Million Growth Debt Facility from Claret Capital Partners to Accelerate Commercial Expansion
View Neurent Medical Secures €25 Million Growth Debt Facility from Claret Capital Partners to Accelerate Commercial ExpansionEurope’s largest independent growth debt fund manager reaches final close; Claret Capital Partners raises €575 million to back Europe’s boldest innovators
View Europe’s largest independent growth debt fund manager reaches final close; Claret Capital Partners raises €575 million to back Europe’s boldest innovatorsClaret in France: In Conversation with Clément Hardy
View Claret in France: In Conversation with Clément HardyClaret Capital Partners backs EdgeTier to accelerate agentic AI-powered customer insight
View Claret Capital Partners backs EdgeTier to accelerate agentic AI-powered customer insightClaret Capital Partners provides €30m financing to Carvolix to accelerate commercialisation of medtech portfolio
View Claret Capital Partners provides €30m financing to Carvolix to accelerate commercialisation of medtech portfolioFunding the float: Why Venture Debt fits Cross-border Payments
View Funding the float: Why Venture Debt fits Cross-border PaymentsClaret H1 2026: A Half-Year in Review
View Claret H1 2026: A Half-Year in ReviewFunding at the Speed of the Science. Why venture debt belongs in the late-stage therapeutics capital stack
View Funding at the Speed of the Science. Why venture debt belongs in the late-stage therapeutics capital stack€1.5bn deployed: Claret backs 200+ companies across technology, life sciences and impact
View €1.5bn deployed: Claret backs 200+ companies across technology, life sciences and impactClaret Capital Partners participates in €130m financing for Inventiva
View Claret Capital Partners participates in €130m financing for InventivaClaret wins Debt Funding Deal of the Year (<€10M) at the Irish Investor Awards 2026 with Neurent Medical
View Claret wins Debt Funding Deal of the Year (<€10M) at the Irish Investor Awards 2026 with Neurent MedicalFund your growth while minimising dilution
Investing in Europe's leading disruptive businesses.
€
0
bn
Total capital deployed across Europe since inception.
€
0
bn
Capital Raised
0
+
European SMEs backed across technology, life sciences and climate tech.
Selected investments:
FOUNDER & CEO CORNER
Further Reading
Investment Announcement
14 Sep 2026
Open Cosmos raises €300 million to accelerate real-time intelligence and connectivity from space
View Open Cosmos raises €300 million to accelerate real-time intelligence and connectivity from space
Investment Announcement
9 Sep 2026
Neurent Medical Secures €25 Million Growth Debt Facility from Claret Capital Partners to Accelerate Commercial Expansion
View Neurent Medical Secures €25 Million Growth Debt Facility from Claret Capital Partners to Accelerate Commercial Expansion
Claret News
7 Sep 2026
Europe’s largest independent growth debt fund manager reaches final close; Claret Capital Partners raises €575 million to back Europe’s boldest innovators
View Europe’s largest independent growth debt fund manager reaches final close; Claret Capital Partners raises €575 million to back Europe’s boldest innovators
Claret Insight
2 Sep 2026
Claret in France: In Conversation with Clément Hardy
View Claret in France: In Conversation with Clément Hardy
Investment Announcement
18 Aug 2026
Claret Capital Partners backs EdgeTier to accelerate agentic AI-powered customer insight
View Claret Capital Partners backs EdgeTier to accelerate agentic AI-powered customer insight
Investment Announcement
6 Aug 2026
Claret Capital Partners provides €30m financing to Carvolix to accelerate commercialisation of medtech portfolio
View Claret Capital Partners provides €30m financing to Carvolix to accelerate commercialisation of medtech portfolio
Claret Insight
20 Jul 2026
Funding the float: Why Venture Debt fits Cross-border Payments
View Funding the float: Why Venture Debt fits Cross-border Payments
Claret News
14 Jul 2026
Claret H1 2026: A Half-Year in Review
View Claret H1 2026: A Half-Year in Review
Claret Insight
7 Jul 2026
Funding at the Speed of the Science. Why venture debt belongs in the late-stage therapeutics capital stack
View Funding at the Speed of the Science. Why venture debt belongs in the late-stage therapeutics capital stack
Claret News
2 Jul 2026
€1.5bn deployed: Claret backs 200+ companies across technology, life sciences and impact
View €1.5bn deployed: Claret backs 200+ companies across technology, life sciences and impact
Investment Announcement
16 Jun 2026
Claret Capital Partners participates in €130m financing for Inventiva
View Claret Capital Partners participates in €130m financing for Inventiva
Claret News
19 May 2026